TI POTREBBE INTERESSARE: Diventa rimborsabile un nuovo farmaco per l’ipertensione arteriosa polmonare ... LEGGI TUTTO #farmaci #salute #ipertensione #rimborsabilità #sotatercept
Zum Thema #iPAH: Meine Werte sind etwas schlechter als mit #Remodulin, aber es war laut Arzt klar, dass #Sotatercept nicht ganz so effektiv wirkt. Da Sotatercept mir insgesamt mehr Lebensqualität bietet (1 Injektion alle 3 Wochen statt dauerhaft Pumpe) und alles in allem gut wirkt, kann ich…
Winrevair® de Merck aprobado en China: Nueva era contra la HAP | Sotatercept
📩 info@dengyuemed.com
🔗https://dengyuepharma.com
#HAP #HipertensionArterialPulmonar #Winrevair #Sotatercept #Merck #InnovacionMedica #SaludPulmonar
🎉 Félicitations au Pr Marc Humbert, lauréat du Grand Prix @inserm.fr 2025 !
Ses travaux ont transformé la prise en charge de l’#HTAP et ouvert la voie à de nouvelles thérapies.
👉 À lire : www.inserm.fr/en/news/marc...
#HypertensionPulmonaire #MaladiesRares #Recherche #Sotatercept #Innovation
Proud to share our new CIRCULATION paper, released alongside our #AHA2025 presentation: Sotatercept rapidly lowers pulmonary pressures and RV afterload within hours.
🔗 www.ahajournals.org/doi/10.1161/...
#AHA2025 #Circulation #PAH #RVFunction #Sotatercept #PeoplesVentricle
Adding the #BiologicDrug #sotatercept to standard therapy within the first year after diagnosis significantly lowers the risk of disease worsening in patients with the most severe form of #PulmonaryHypertension.
#PulmonaryArterialHypertension
🔴 #ERSCongress
Vallerie Victoria McLaughlin, #Michighan, expose les données de l'étude #HYPERION concernant le #sotatercept pour les patients #HTAP nouvellement diagnostiqués.
#PHA #PulmoTension
@phassociation.org
@montanidavid.bsky.social
#PVRI2026 includes sessions on promising novel targets and pathways in #PAH, along with real-world data of #Sotatercept.
🗓️ Get your #abstract in before the closing date of 01 October!
🎟️ Register soon to secure a place in one of the PVRI reserved hotels!
pvrinstitute.org/pvri2026
Miss our #PVRIdigital Webinar: #Sotatercept: New Concepts & Clinical Use? PVRI members can watch it on demand: pvrinstitute.org/learning-and... - this webinar is part of the 'Cutting Edge Innovation in Clinical & Experimental PH' sessions.
How to define or prove disease modification - catch up on @mark-toshner.bsky.social thought-provoking talk from #DDDS2025 🎥
pvrinstitute.org/learning-hub...
#PAH #BMP #Imatinib #Sotatercept #DiseaseModification
Bauch mit Mini-Katheter, von dem ein Schlauch zu einer Pumpe führt.
Heute kommt die Pumpe weg. #PAH Ich habe Glück, das #Sotatercept scheint bei mir so gut zu wirken, dass ich nur noch täglich (reichlich) Tabletten sowie alle drei Wochen eine Injektion brauche. #GuteNachrichten #PulmonaleArterielleHypertonie
🎥 Missed #DDDS2025 in Amsterdam?
Catch Luke Howard’s talk: How Sotatercept will change the treatment algorithm 💊
▶️ Full recording: pvrinstitute.org/learning-hub...
#PHResearch #DrugDevelopment #Sotatercept #PVRI
Apparemment, le #Sotatercept fonctionne bien. À partir de la semaine prochaine, nous réduisons la dose de #Remodulin et, avec beaucoup de chance, je pourrai peut-être vivre sans pompe à partir de début août. C'est un sentiment étrange, un mélange d'espoir, d'excitation et d'insécurité, c'est sûr !
So, apparently #Sotatercept works fine in my body. Beginning next week we are reducing #Remodulin and if I am VERY, VERY lucky I may live without a pump from the beginning of August on. It’s a strange feeling, a mixture of hope, excitement and insecurity for sure! #PAH #PulmonaryArterialHypertension
Join our upcoming April Community Call! We’ll be diving into:
- A long-term follow-up study of Sotatercept for PAH
- Lysosomal dysfunction & inflammatory sterol metabolism in PAH
📍 Free to attend – all welcome!
📅 24 April 2025, 16:00 BST
pvrinstitute.org/learning-hub... #PAH #webinar #Sotatercept
#ZENITH Phase 3 RCT: #Sotatercept in High-Risk PAH
✅ Reduced primary endpoint events: 17.4% vs. 54.7% (HR 0.24, P < 0.001)
✅ Lower mortality: 8.1% vs. 15.1%
✅ Fewer PAH 🏥: 9.3% vs. 50.0%
✅ Lower lung transplant rate: 1.2% vs. 7.0%
🩸 Most common AEs: epistaxis, telangiectasia
@nejm.org
Missed Ravikumar Sitapara's talk on the combination of seralutinib & sotatercept in preclinical models at #PVRI2025? Now’s your chance to catch up! 🎦 Watch the full talk on demand now pvrinstitute.org/learning-hub... #PAH #seralutinib #sotatercept
#ACC
【新規PAH治療薬で高リスク例の増悪有意抑制:RCT/ NEJM】
最大限の従来治療下にて「WHO分類 III度以上」で「1年死亡高リスク」の肺高血圧172例ランダム化、10,6か月 [中央値] 観察:
・ソタテルセプトでプラセボに比べ、「死亡・胚移植・PAH増
悪入院」HRは0.24 [95%CI:0.13-0.43]。NNTは「3」。
・重篤有害事象発生率に有意差なし。
x.gd/CYzgl
#PAH #Sotatercept
🚨 ‼️ 🫀🫁 #PHPEEPS
Sharing an important and impactful study published today in @nejm.org : The #ZENITH trial of #sotatercept for high-risk patients with pulmonary arterial hypertension #pah.
Reduction in morbidity/mortality HR, 0.24; 95%CI, 0.13 to 0.43.
www.nejm.org/doi/full/10....
Anruf gerade vom Krankenhaus: Das #Sotatercept wirkt. Die Zufuhr des Remodulins via Pumpe kann nach und nach heruntergefahren und dann beendet werden. Stattdessen nur noch täglich Tabletten sowie alle drei Wochen Sotatercept-Injektion. Ich könnte heulen❣️ #GuteNachrichten #PAH
✨️ Toutes nos félicitations aux 3 lauréates 🎉 :
🔹️ Athénaïs Boucly, CRMR #PulmoTension @Bicetre pour #HTAP #biomarqueurs #sotatercept
🔹️ Florence JENY, CRMR #OrphaLung @Avicenne pour la #sarcoïdose #facteursenvironnementaux
🔹️ Julie MAZENQ, CRMR #RespiRare @APHM en SHS, ventilation, #SAOS
🔴 en direct #CPLF2025 Retour sur le 7ème congrès de l’#HTP, Le Pr Marc Humbert, @hopitalbicetre.bsky.social, présente les avancées thérapeutiques dans les #HTAP : l’introduction des thérapies émergentes dans l’algorithme thérapeutique notamment le #Sotatercept qui bloque la voie du #TGF-beta
www.linkedin.com/pulse/breakt...
Breakthrough for Pulmonary Hypertension: Sotatercept Gets MHRA Nod
kstrategyand.com/pharma-news
#Winrevair #Sotatercept #PAHTreatment #PulmonaryHypertension #MedicalBreakthrough #MHRAApproval #SelfInjectionTherapy #Humanteconomy #Humantec #KStrategyand
2000+ CDNs have Pulmonary Arterial Hypertension. #Sotatercept (Winrevair™) offers hope, but many don’t have access without public funds, #SylviaJones #DougFord prioritize funding for this life-saving drug #PHAwareness #onpoli #TimeMattersPAH @bonnieforontario.bsky.social @maritstilesndp.bsky.social
#HappyHalloween 🎃 👻 Gleich mal die zusätzlichen Spritzen aus dem #Sotatercept Kit zweckentfremdet… 🤪 #PulmonaleHypertonie